Abstract
Gestational trophoblastic diseases (GTD) are a group of heterogenous disease that arise from the trophoblast; and range from premalignant conditions like partial and complete hydatidiform moles to malignant lesions like invasive hydatidiform moles, choriocarcinoma and the rarer placental site trophoblastic and epithelioid tumours [1–7]. The malignant forms of the disease that will need chemotherapy are collectively called gestational trophoblastic neoplasms (GTN) [1].
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
14.1 Introduction
Gestational trophoblastic diseases (GTD) are a group of heterogenous disease that arise from trophoblast; and range from premalignant conditions like partial and complete hydatidiform moles to malignant lesions like invasive hydatidiform moles, choriocarcinoma and the rarer placental site trophoblastic and epithelioid tumours [1,2,3,4,5,6,7]. The malignant forms of the disease that will need chemotherapy are collectively called gestational trophoblastic neoplasms (GTN) [1].
The incidence of GTD is higher in Asian (1 in 500) and African (1 in 1000) than European or American (1 in 1500) population [3, 4, 7]. The incidence of molar pregnancy in India is 1 in 400 pregnancies [8]. About 80% of GTDs are hydatidiform moles. Risk factors for the development of hydatidiform moles include extremes of age, ethnicity, history of spontaneous miscarriage and dietary deficiencies [9]. Women between 21 and 35 years of age have a lower incidence than women younger than 21 years or older than 35 years [10]. The etiopathology, diagnosis, presentation and management of GTDs have been described previously. This chapter will outline the critical situations encountered with GTDs.
14.2 Critical Events
GTDs entail a variety of presentations secondary to their endocrine, secretory, angiogenic and other properties. Presentations may sometimes be extremely perplexing and not fit into any clinical situation. Presentation may be sometimes so acute that GTD is occasionally diagnosed for the first time in ICU. The presentation is often acute or subacute and clinicians need to keep a high risk of suspicion of GTDs in all women in the reproductive age group [11].
14.2.1 Haemorrhage
Excessive vaginal bleeding is known to occur with GTDs [11]. This may be due to the production of high levels of angiogenic growth factors which remodel the uterine vasculature and lead to the formation of arteriovenous malformation. Although more commonly seen in choriocarcinoma, abnormal uterine bleeding may be seen in complete hydatidiform mole and placental-site trophoblastic disease [11]. Due to the chance of significant bleeding during procedures like suction evacuation of hydatidiform mole, RCOG guidelines (2010) advocate the presence of a senior surgeon (Fig. 14.1) [12]. Blood should also be kept cross-matched in the event of sudden post-procedure haemorrhage. Bleeding and shock does sometimes occur remote from the procedure. Hence proper counselling for a strict followup and appraisal of complications that could ensue will go a long way in reducing the preventable morbidity and mortality.
The use of oxytocics before the evacuation of molar pregnancy is not recommended because of the theoretical concern of the trophoblastic material embolising through the uterine venous plexus into the systemic veins [12]. However, to control life-threatening bleeding, infusions of oxytocics may be required. Similarly, preparation of the cervix with prostaglandins and use of sharp curettage is also not recommended [13]. Apart from major bleeding during the evacuation of molar pregnancy, acute cardiopulmonary distress and adult respiratory distress syndrome have also been reported after suction evacuation in 27% of cases.
Haemorrhage may not be only confined to vaginal bleeding. Excessive haemorrhage has also been reported in the gastrointestinal tract and patients may present with excessive haematemesis and melena or lower gastrointestinal tract bleeding [14, 15]. Unexplained anaemia is often seen in these patients and may or may not be associated with masses in the small bowel or colon [16]. Rarer manifestations include recurrent epistaxis along with abnormal vaginal and rectal bleeding [11]. Bleeding leading to a painful eye with decreased visual acuity has also been reported [11]. Torrential bleeding may happen from suburetrhral nodule (Fig. 14.2). Stitches may be difficult to fix. Styptics , local and systemic, with packing may be helpful at times. Hence biopsy from such nodules is not only unnecassary but may be lethal at times.
14.2.2 Perforation and Spontaneous Uterine Rupture
There are case reports of spontaneous uterine perforation in patients with choriocarcinoma [17, 18]. The possible mechanisms are invasion of blood vessels by the trophoblastic cells leading to uterine infarction at multiple sites due to thrombosis, aneurysm formation and tumoral bleeding [11]. Other possible causes of uterine rupture are invasion of the uterine endometrium and myometrium by tumour cells or tumour necrosis due to chemotherapy [11]. Such patients may present with signs and symptoms of acute abdomen and emergency hysterectomy may have to be performed. Massive hemoperitoneum occurring days after suction and evacuation procedure may occur when the invasive component of the disease has been missed or may accrue after the procedure (Fig. 14.3). Hence, thorough counselling of patients for strict follow-up is the onus of the consultant. Treatment is always surgical. Segmental resection is the treatment of choice. The patient is often hemodynamically unstable and hence needs utmost attention.
14.2.3 Systemic Signs of Tumour Metastasis
The lung parenchyma is the most common site of metastasis in patients with choriocarcinoma and patients may present with signs and symptoms of acute respiratory failure like dyspnoea, acute chest pain with or without haemoptysis [19] and sudden onset of pulmonary hypertension due to pulmonary embolism (Fig. 14.4) [20]. In fact, the differential diagnosis of choriocarcinoma should be kept in mind in a young woman presenting with sudden onset of pulmonary hypertension due to pulmonary embolism without any other antecedent risk factors [11]. Women may land up in pulmonary medicine department leading to delay in treatment and detorioration, which is sometimes acute and sudden. Hence a element of suspicion in women of reproductive age group is worth a life.
Central nervous system involvement occurs in 10% of patients with choriocarcinoma and has varied manifestations [11]. Tumour metastasis to the central nervous system is also common which manifests as raised intracranial pressures and seizures [11]. Surgical intervention in the form of emergency craniotomy to release intracranial pressure has been done with encouraging results. Sudden onset of stroke-like symptoms have also been reported with hemiparesis and facial palsy due to multiple intracerebral haemorrhages from aneurysmal vessels in the brain [21]. Though challenging, treatment of seemingly hopeless cases does benefit in majority of cases.
14.2.4 Acute Abdomen
Acute abdomen has been reported in patients with GTDs due to rupture and haemorrhage, intussusception and extrauterine sites of implantation mimicking ruptured ectopic pregnancy [11, 22]. Massive intraperitoneal haemorrhage has also been reported but may be due to variable aetiology like ruptured liver or spleen or a ruptured blood vessel [11]. Involvement of the kidney causes symptoms and signs of acute flank pain with hematuria and renovascular hypertension [23]. In fact, on many occasions, the abdomen has been opened suspecting ruptured ectopic or intestinal perforation and has been later found to be GTD [11]. GTD of fallopian tubes may present exactly like ruptured ectopic and proved only by a postoperative histopathologic study of the removed appendage.
14.2.5 Thyrotoxicosis
The similar structure of the human chorionic gonadotrophin (hCG) and thyroid-stimulating hormone causes hCG to exert a thyrotrophic action and signs and symptoms of thyrotoxicosis such as hypertension, tachycardia, atrial fibrillation and congestive cardiac failure has been reported in these patients (Fig. 14.5) [24]. So, the differential diagnosis of GTDs should always be kept in mind in a woman after any pregnancy event presenting with signs and symptoms of thyrotoxicosis and both serum hCG as well as thyroid hormone assay should be performed [11].
14.2.6 Acute Vascular Events
Due to the presence of a hypercoagulable state, venous and arterial thromboembolism may occur [25]. Activation of platelets and factors XII and X due to tumour cell–macrophage interaction causes the release of cytokines like TNF-alpha and interleukins leading to endothelial damage. Other risk factors may be the toxicity of chemotherapeutic agents [11].
14.2.7 Sepsis
Clostridium perfringens induced sepsis has been reported in a case of invasive molar pregnancy. The necrotic tumour tissue creates hypoxic and ischaemic conditions that allow the proliferation of this anaerobic Gram-positive bacillus leading to the formation of gas gangrene [26]. In this particular case, the sepsis is resolved after hysterectomy leading to removal of the septic foci [26]. Similarly, previous reports exist of association of clostridium infections in patients with choriocarcinoma [27].
14.2.8 Ovarian Hyperstimulation Syndrome
This condition is typically seen in patients following ovulation induction and consists of enlarged ovaries, with multiple follicular cysts and acute fluid shifts from intravascular space to the extracellular space, causing haemoconcentration, oedema, electrolyte disturbances and massive pleural effusion, ascites and pericardial effusions in severe cases leading to acute thromboembolic events and even death. Although sometimes seen in twin pregnancy, ovarian hyperstimulation syndrome has been reported 3 days after molar pregnancy evacuation [28]. It is likely that the high levels of hCG cause bilateral ovarian stimulation and enlargement. Young women presenting with ascites and enlarged ovaries and raised B HCG may be mistaken for germ cell tumour of ovaries and careful decision needs to be taken along with a history of recent termination of pregnancy.
14.2.9 Chemotherapy
Occasionally very high-risk cases with large tumour burden may present with an acute serious illness due to tumour lysis and haemorrhage. Though seemingly hopeless, careful management of these cases will help them survive as they are potentially curable. Alternatively, low-dose Etoposide 100 mg/m2 and cisplatin 20 mg/m2 (EP) induction chemotherapy for patients with high-volume disease is a better and safer option. Ensuring adequate hydration, commencing therapy with allopurinol or raspuricase and special attention to electrolyte balance and renal function has reduced the rates of early deaths [29]. Fatal pulmonary haemorrhage may occur due to positive pressure ventilation as the vessels are very friable; hence, low pressure is recommended. Tumour lysis may sometimes lead to multiorgan failure and death. Life-threatening myelosuppression is sometimes a crisis to manage vigourously.
14.2.10 Critical Situations During Surgery
There is a chance of embolisation of the trophoblastic tissue; hence, minimal manipulation and prophylactic or perioperative CT is proposed by some to be another method to prevent embolisation. Patients are usually anaemic and hemodynamically unstable and need added attention and precaution. Extensive vascular supply and the friable nature of the uterus may lead to extensive intra-op blood loss that has to be handled properly and fast. Sometimes, unrecognised extrauterine disease may pose a challenge. DIC, though rare, should be kept in mind. Hence, it is always advisable to handle surgery in GTD by an experienced surgical team along with an adequate blood transfusion facility and ICU backup.
14.2.11 Unstable Patients
An extensive metastatic burden and hCG levels of over 500,000 IU/L behave unpredictably. An initial treatment with MTX infusion/leucovorin rescue or Etoposide 100 mg/m2 ± cisplatin 50–75 mg/m2 is sometimes given to avoid catastrophic haemorrhage from high-risk sites of metastases. EMA/CO is initiated as soon as the condition improves.
14.2.12 Adnexal Torsion and Theca Leutin Cyst Rupture
Present with acute abdomen and need immediate treatment.
14.2.13 Thyroid Crisis
High levels of HCG are typically required for the development of clinical hyperthyroidism. Iodinated substances can trigger a crisis (Jod Basedow phenomenon). Rarely the thyroid stimulation can have potentially life-threatening consequences. Carbimazole and β-blockers for symptom relief appear to be effective. Thyroid function normalises rapidly with treatment of the underlying GTD and the consequent fall in HCG levels [30].
14.3 Conclusion
GTDs constitute a clinical conundrum and often the first presentation to the hospital is because of an acute or subacute crisis. Clinicians will likely encounter such women in their practice and therefore need to be aware of the varied critical events that may manifest in these women. Often, the diagnosis may not be readily apparent as the heterogeneity of the disease leads to signs and symptoms that are present in other organs. Therefore, a high index of suspicion of GTDs should be kept in mind while attending to women in the reproductive age group presenting with an acute or subacute crisis. Overall, definitive care for GTN is the purview of the gynaecologist but the emergency physicians should be aware of the risks and be able to recognise the patient with this potentially lethal but curable disease.
References
Seckl MJ. Gestational trophoblastic disease: clinical presentation and treatment. Diagn Histopathol. 2018;25(2):77–85.
Ngan HY, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2015;131(suppl 2):S123–6.
Steigrad SJ. Epidemiologyofgestationaltrophoblasticdiseases. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):837–47.
Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4(11):670–8.
Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades: a Korean experience. J Reprod Med. 1998;43(1):60–8.
Seckl MJ, Sebire NJ, Berkowitz RS. Gestationaltrophoblastic disease. Lancet. 2010;376(9742):717–29.
Lurain JR. Gestationaltrophoblasticdisease. I. Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531–9.
Dutta DC. Haemorrhage in early pregnancy. In: Konan H, editor. Textbook of obstetrics. 6th ed. Kolkata: New Central Book Agency; 2004. p. 159–202.
Nadhan R, Vaman JV, Nirmala C, et al. Insights into dovetailing GTD and cancers. Crit Rev Oncol Hematol. 2017;114:77–90.
Newlands ES, Paradinas FJ, Fisher RA. Recent advances in gestational trophoblastic disease. Hematol Oncol Clin North Am. 1999;13(1):225–44.
Mangla M, Singla D, Kaur H, Sharma S. Unusual clinical presentations of choriocarcinoma: a systematic review of case reports. Taiwan J Obstet Gynecol. 2017;56:1–8.
The management of gestational trophoblastic diseases. Green-top guidelines. Royal College of Obstetricians and Gynaecologists. 2010. p. 1–12.
Stone M, Bagshawe KD. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol. 1979;86(10):782–92.
Villet WT, Du Toit DF, Conroy C. Unusual presentation of choriocarcinoma. A case report. S Afr Med J. 1979;55:96e8.
Suski E, Pavlides C, Matsumoto T. Massive lower gastrointestinal bleeding: unusual presentation of metastatic choriocarcinoma. Int Surg. 1979;64:53e5.
Chaturvedi M, Vaideeswar P, Pandit A. Metastatic Choriocarcinoma: an unusual cause of severe anemia. J Postgrad Med. 2005;51:230e1.
Xie C, Zheng L, Li Z, Zhao X. Spontaneous uterine perforation of choriocarcinoma with negative beta-human chorionic gonadotropin after chemotherapy. Med Princ Pract. 2011;20:570e3.
Okamoto T, Nomura S, Nakanishi T, Yamada S, Tomoda Y. A case of uterine choriocarcinoma with spontaneous rupture twenty-three years following theantecedent pregnancy. J Obstet Gynaecol Res. 1997;23:189e95.
Berkowitz RS, Goldstein DP. Gestational trophoblastic disease. In: Berek J, editor. Berek& Novak’s gynecology. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1581e603.
Gangadharan VP, Chitrathara K, Sivaramakrishnan R, Satishkumar K, Nair MK. Pulmonary hypertension: a rare presentation of choriocarcinoma. Acta Oncol. 1993;32:461e2.
Daniel CN, Ango IG, Nwobodo EI. Choriocarcinoma with cerebral metastasis presenting as a stroke like lesion. Sahel Med J. 2015;18:16e9.
Mittal S, Aird I, Haugk B. Gestational choriocarcinoma in liver mimicking ruptured ectopic pregnancy. J Obstet Gynaecol. 2012;32:499.
Usta TA, Karacan T, Ozyurek E, Naki MM, Omeroglu SN, Demirkiran F. Primary renal artery choriocarcinoma causing secondary renovascular hypertension. Int J Surg Case Rep. 2014;5:1197e9.
O'Reilly S, Lyons DJ, Harrison M, Gaffney E, Cullen M, Clancy L. Thyrotoxicosis induced by choriocarcinoma a report of two cases. Ir Med J. 1993;86:124e7.
Cyriac S, Sagar TG, Mahajan V. Choriocarcinoma with arterial and venous thrombosis. Neurol India. 2009;57:505e7.
Singh S, Angra K, Bonnie D, Shokrani B. Complications of invasive molar pregnancy with clostridium perfringes sepsis. Case Rep Obstet Gynaecol. 2014:Article ID 282141.
Chern-Horng L, Hsieh SY. Clostridium septicum infection presenting as liver abscess in a case of choriocarcinoma with liver metastasis. J Gastroenterol Hepatol. 1999;14(12):1227–9.
Arora R, Merhi ZO, Khulpateea N, et al. Ovarian hyperstimulation syndrome after a molar pregnancy evacuation. Fertil Steril. 2008;90(4):1197.e5–7.
Agarwal R, et al. Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995–2010. J Reprod Med. 2014;59(12):7–12.
Walkington L, et al. Hyperthyroidism and human chorionic gonadotropin production in gestational trophoblastic disease. Br J Cancer. 2011;104:1665–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nayak, B., Singh, S. (2021). Critical Situations in Gestational Trophoblastic Diseases. In: Nayak, B., Singh, U. (eds) Gestational Trophoblastic Disease. Springer, Singapore. https://doi.org/10.1007/978-981-33-4878-3_14
Download citation
DOI: https://doi.org/10.1007/978-981-33-4878-3_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4877-6
Online ISBN: 978-981-33-4878-3
eBook Packages: MedicineMedicine (R0)